Entries by CURC

The Addition of Docetaxel to Androgen Deprivation

/in /by

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][su_button url=”http://www.researchtopractice.com/COCP15/1/Matrix?utm_medium=email&utm_campaign=CoC%20Prostate%2015%20Issue%201%20NEW&utm_content=CoC%20Prostate%2015%20Issue%201%20NEW+CID_b67d75bca224c4900aa23738285106ba&utm_source=Email%20marketing%20software#” target=”blank” background=”#024458″ size=”5″]View Article[/su_button][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

New Biomarkers in Prostate Cancer

/in /by

Was cited as one of the top 5 oncology review article by Journal Oncology for 2014. By Neal D. Shore, MD, E. David Crawford, MD and Karen Ventii, PhD. [fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][su_button url=”http://www.cancernetwork.com/oncology-journal/new-biomarkers-prostate-cancer?GUID=9D7B2BB9-68D4-47DF-8BAA-E3C747BE5D8A&XGUID&rememberme=1&ts=02012015″ target=”blank” […]

Targeted Immunotherapy for Prostate Cancer with PROSTVAC

/in /by

Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC targeted immunotherapy for prostate cancer. [fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][su_button url=”http://www.cancertherapyadvisor.com/prostvac-prostate-cancer-immunotherapy-results/article/380602/?DCMP=EMC-CTA_weekly_rd&CPN&spMailingID=9814940&spUserID=MzA3NTMwMjM2MTAS1&spJobID=420205585&spReportId=NDIwMjA1NTg1S0″ target=”blank” background=”#024458″ size=”5″]View Article[/su_button][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

Genomic Testing for Newly Diagnosed Low-Risk Prostate Cancer

/in /by

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][su_button url=”http://www.onclive.com/oncotypedx?utm_source=Informz&utm_medium=OncLive&utm_campaign=Onco+DX+iPub+09-19-14″ target=”blank” background=”#024458″ size=”5″]View Article[/su_button][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]